| |
| |
|
| Insider
Information: |
Glenn Gregory M |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,339 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,339 |
|
|
| Total
Value |
$6,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2023-03-10 |
18,339 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-08-18 |
4 |
OE |
$25.60 |
$1,876,525 |
D/D |
55,921 |
57,760 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-08-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,528 |
311 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$2,116,645 |
D/D |
(18,639) |
21,510 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,588 |
40,149 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$148,750 |
D/D |
25,000 |
46,510 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
21,510 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-29 |
4 |
AS |
$106.17 |
$2,134,844 |
D/D |
(19,949) |
1,561 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
AS |
$272.42 |
$1,614,812 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
OE |
$5.95 |
$138,577 |
D/D |
10,531 |
7,630 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
D |
$262.70 |
$28,897 |
D/D |
(110) |
7,520 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
D |
$262.70 |
$597,643 |
D/D |
(2,275) |
5,245 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-18 |
4 |
AS |
$264.09 |
$656,134 |
D/D |
(2,434) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
D |
$217.46 |
$492,329 |
D/D |
(2,264) |
5,234 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
D |
$217.46 |
$28,705 |
D/D |
(132) |
7,498 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
OE |
$5.95 |
$1,157,843 |
D/D |
10,531 |
7,630 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
AS |
$196.88 |
$1,134,400 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-17 |
4 |
AS |
$210.85 |
$530,304 |
D/D |
(2,423) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
D |
$202.09 |
$456,723 |
D/D |
(2,260) |
5,228 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
D |
$202.09 |
$28,697 |
D/D |
(142) |
7,488 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
OE |
$5.95 |
$1,083,775 |
D/D |
10,531 |
7,630 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
AS |
$196.77 |
$1,144,387 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-19 |
4 |
AS |
$213.79 |
$531,052 |
D/D |
(2,417) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-05-17 |
4 |
D |
$140.16 |
$28,733 |
D/D |
(205) |
7,425 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-05-17 |
4 |
AS |
$131.50 |
$765,267 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-05-17 |
4 |
OE |
$5.95 |
$138,577 |
D/D |
10,531 |
7,630 |
0 |
- |
|
128 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
